array(2) { ["lab"]=> string(4) "1146" ["publication"]=> string(4) "9488" } Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy - 胃癌基础与临床转化研究实验室 | LabXing

Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy

2016
期刊 Oncotarget
下载全文